Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Cardiac expression of deiodinase type 3 (Dio3) following myocardial infarction is associated with the induction of a pluripotency microRNA signature from the Dlk1-Dio3 genomic region.

Endocrinology | 2013

The adult heart has almost completely lost the proliferative potential of the fetal heart. Instead, loss of cardiomyocytes due to myocardial infarction (MI) leads to a limited, and often insufficient, hypertrophic response of cardiomyocytes in the spared myocardium. This response is still characterized by a partial reexpression of the fetal gene program. Because of the suggested involvement of microRNAs (miRNAs) in cardiac remodeling, we examined the miRNA expression profile of the spared left ventricular myocardium using a MI mouse model. C57Bl/6J mice of either sex were randomly assigned to the sham-operated group or MI group. MI was induced by ligation of the left coronary artery. One week after surgery RNA was isolated from the left ventricle. MiRNA analysis was performed using the Taqman Megaplex rodent array. Unexpectedly, we found a set of 29 up-regulated miRNAs originating from the Dlk1-Dio3 genomic imprinted region, which has been identified as a hallmark of pluripotency and proliferation. This miRNA signature was associated with a 6-fold increase in expression of the deiodinase type 3 gene (Dio3) located in this region. Dio3 is a fetally expressed thyroid hormone-inactivating enzyme associated with cell proliferation, which was shown to be up-regulated in cardiomyocytes creating a local hypothyroid condition in the spared myocardium in this model. These data suggest that a regenerative process is initiated, but not completed, in adult cardiomyocytes after MI. The identified miRNA signature could provide new ways to manipulate the in vivo response of adult cardiomyocytes to stress and to increase the regenerative capacity of the injured myocardium.

Pubmed ID: 23554452 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-GLUT-4, C-terminus (antibody)

RRID:AB_1587080

This polyclonal targets GLUT-4 C-terminus

View all literature mentions

Glut1 (H-43) (antibody)

RRID:AB_2190936

This polyclonal targets SLC2A1

View all literature mentions

Na+/K+-ATPase alpha (H-300) (antibody)

RRID:AB_2290063

This polyclonal targets ATP1A3, ATP1A1, ATP1A2

View all literature mentions

Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb (antibody)

RRID:AB_2315049

This monoclonal targets Phospho-Akt (Ser473)

View all literature mentions

Goat Anti-Actin Polyclonal antibody, Unconjugated (antibody)

RRID:AB_630836

This polyclonal targets ACTG1, ACTC1, ACTA1, ACTA2, ACTG2, ACTB

View all literature mentions

ERα Antibody (MC-20) (antibody)

RRID:AB_631470

This polyclonal targets ERα

View all literature mentions

Glut4 (N-20) (antibody)

RRID:AB_631577

This polyclonal targets Glut4 (N-20)

View all literature mentions

IRS-1 (C-20) (antibody)

RRID:AB_631842

This polyclonal targets IRS-1 (C-20)

View all literature mentions

Akt1 (D-17) (antibody)

RRID:AB_633762

This polyclonal targets AKT1

View all literature mentions